Vanaja Sundar Iyer is no longer listed among Bajaj Healthcare Limited's disclosed shareholders, leaving it unknown whether she fully exited her 1.58 percent stake or reduced it below the 1 percent reporting threshold.
A pharmaceutical manufacturer established in 1993, Bajaj Healthcare produces active pharmaceutical ingredients and formulations for domestic and international markets. The company operates across multiple therapeutic segments, serving hospitals, clinics, and retail pharmacies with a comprehensive product portfolio. Its vertically integrated operations span manufacturing, quality control, and distribution networks across India, supported by research and development capabilities in drug formulation and process optimization.
Compared frequently to Dolly Khanna, for good reason. Vanaja Sundar Iyer quietly builds positions in manufacturing, automotive, industrials, chemicals, and real estate that India's fund managers don't own. Her ~₹888-1,198 Cr disclosed portfolio includes Tanfac Industries, Vesuvius India, and Force Motors, a track record of multi-year multibaggers in deeply under-followed companies. Chennai-based. No hype, just performance.